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Abstract: 
This study aimed to investigate the cytoprotective effects of flavonoids, their metabolites  alone or in combination against hypoxia/reoxygenation 
induced oxidative stress in the transformed human first trimester trophoblast cell line (HTR-8/SVneo). 
Oxidative stress was achieved with hypoxia followed by reoxygenation and the following assays were performed: MTT, CellTox™ Green 
Cytotoxicity, CellTiter-Glo®, NADP/NADPH-Glo™, ROS-Glo™/H2O2, GSH/GSSG-Glo™ and Caspase-Glo® 3/7 assays. 
HTR-8/SVneo cells, pre-treated for 24 h with flavonoids or their metabolites were protected significantly from oxidative stress. Flavonoids were 
associated with ROS modulation, reducing the generation of superoxide/hydrogen peroxide. The activities of caspases 3/7 were also significantly 
reduced significantly in HTR-8/SVneo cells pre-treated with flavonoids. 
This study has shown for the first time that 24 h pre-treatment with flavonoids, their metabolites alone or in combination, protected against HR-
induced oxidative stress in the trophoblast cell line. These data indicate that dietary flavonoids may be beneficial to placental health and invasion 
during early gestation.  
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1.0 Introduction: 
Flavonoids are a large group of phenolic plant chemicals with significant antioxidant and chelating properties. They are widely distributed in seeds, 
fruits, vegetables, bark, leaves and flowers. Although their bioactive potentials have been recognised for some time, data relating to their 
bioavailability, health effects and metabolic fate has come to light only in the past two decades (Banjarnahor & Artanti, 2014; Iris Erlund, 2004; 
Heim, Tagliaferro, & Bobilya, 2002). In addition to their antioxidant properties, flavonoids have been reported to exhibit multiple biological 
properties. These include anticancer (prostate, breast, colon and lungs), cardioprotection (mainly athero-protection), antiviral, anti-inflammatory, 
anti-aging and anti-neurodegenerative effects (against Alzheimer’s disease) (Daubney, Bonner, Hargreaves, & Dickenson, 2015; Procházková, 
Boušová, & Wilhelmová, 2011; Q. Zhang, Liu, & Ruan, 2017; Zhang et al., 2015). The mechanisms behind their beneficiary properties is yet to 
be fully understood. In recent years, emphasis has increased on their antioxidant properties, particularly their ability to scavenge free radicals. 
However, flavonoids have also been described to have pro-oxidant properties at high concentrations (D. Procházková et al., 2011). It is conceivable 
that the pro-oxidant properties of flavonoids may trigger protective stress mechanisms that enable tissues/cells to respond to subsequent oxidative 
stress insults.  
Pregnancy is a condition of increased oxidative stress, due to metabolic changes and low-grade inflammation (Ćebović, Marić, Nikolić, & 
Novakov-Mikić, 2013). Dietary flavonoids might help support growing demand for antioxidants during early pregnancy. Early human trophoblast 
invasion occurs in a hypoxic environment (less than 2% Oxygen; Jauniaux et al., 2000). During this time, uterine spiral arterioles are blocked by 
endovascular trophoblast cells (Gude, Roberts, Kalionis, & King, 2004), resulting in release of vasodilator substances, which eventually change 
the spiral arteries from “low-flow high-resistance” to “high-flow low-resistance” vessels (Harris, 2010). However, this short period of hypoxia is 
also associated with the generation of ROS (reactive oxygen species such as peroxides, superoxide, hydroxyl radical). As these reactive oxygen 
species are hazardous to the developing placenta and foetus, there is a tendency to increase demand on natural antioxidant defences, such as 
superoxide dismutase (SOD) and glutathione reductase (GSH) during pregnancy (Ćebović et al., 2013). In support of this, the production of reactive 
oxygen species was found to be higher during the human pregnancy-related hypertensive disorder preeclampsia (PE), which is believed to result 
from poor trophoblast invasion (Cross, Tolba, Rondelli, Xu, & Abdel-Rahman, 2015). Thus, antioxidant therapy has been used during pregnancies 
(Ly et al., 2015) to reduce oxidative stress and, thereby, the incidence of PE (Kiondo et al., 2014; Rani & Naidu, 2016; Rumbold & Crowther, 
2005).  
Although claims of effective use of vitamin supplements to prevent PE were dismissed by Rossi & Mullin, (2011), there is still scope for 
understanding the effects of other naturally occurring antioxidants in fruits and vegetables that would benefit placental health through dietary 
intake. Therefore, this study aims to investigate the antioxidant properties of the main dietary flavonoids (quercetin, and hesperidin) and their 
respective metabolites (quercetin-3-glucoside (Q3G) and hesperetin) against hypoxia/reoxygenation-induced oxidative stress in the transformed 
human first trimester placental cell line HTR-8/SVneo. Here, we report that flavonoids, their metabolites alone or in combination protected against 
hypoxia/reoxygenation-induced oxidative stress. These findings suggest that consumption of certain foods containing bioactive compounds 
(flavonoids) might be beneficial for placental health and invasion.  
2. Materials and Methods 
2.1 Materials 
Thiazolyl blue tetrazolium bromide (MTT) and all flavonoids/ metabolites used in this study were purchased from Sigma-Aldrich® (Poole, UK) 
and their purity was as follows: quercetin (≥95%), hesperidin (≥80%), hesperetin (≥98%) and quercetin 3-glucuronide (≥90%). Dimethyle 
sulfoxide (DMSO) was purchased from Fisher Scientific (Loughborough, UK). CellTox™ green cytotoxicity, CellTiter-Glo® luminescent cell 
viability, NADP/NADPH-Glo™, ROS-Glo™, GSH/GSSG-Glo™ assays were purchased from Promega (Southampton, UK). RPMI-1640, trypsin 
(0.05% w/v) - EDTA (0.02% w/v) solution, penicillin (100 U/ml) and streptomycin (100 µg/ml) were purchased from Lonza (Castleford, UK). 
Foetal bovine serum (FBS) was purchased from Gibco® (Loughborough, UK). A modular incubator chamber was purchased from Billups-
Rothenberg Inc. (San Diego, USA). A gas mixture of 0.2% O2, 5% CO2 and 94.8% N2 was bought from BOC Limited (Nottingham, UK) and 
certified by HiQ® (Nottingham, UK). Absorbance, fluorescence and luminescence were measured using a FLUOstar Omega plate reader (BMG 
LABTECH, Aylesbury, UK). 
2.2 In vitro cell culture 
The transformed first trimester human trophoblast cell line (HTR-8/SVneo) was kindly provided by Dr Charles Graham, University of Kingston, 
Canada (passages used ranged between 32-59). The cells were cultured in RPMI-1640 with L-glutamine supplemented with 10% (v/v) Foetal 
Bovine Serum (FBS), penicillin (100 U/ml) and streptomycin (100 µg/ml) and maintained in a humidified incubator (95% air, 5% CO2 at 37 C) 
until 80-90% confluent. Following this, they were passaged using trypsin (0.05% w/v) - EDTA (0.02% w/v) solution and sub-cultured in a T75 
flask. Cell culture media were changed every two days. In all experiments, except where indicated, the same protocol was followed. Flavonoids 
(quercetin and hesperidin) and metabolites (Q3G and hesperetin) were dissolved in dimethyl sulfoxide (DMSO) to make stock solutions and added 
to the cell culture medium to a final concentration of 0.1%. The same concentration of DMSO (0.1%) alone was added to control cells. 
2.2 Hypoxia/reoxygenation (HR) oxidative stress model 
Hypoxia (0.2% O2) was achieved by placing cultured cells in a humidified modular incubator chamber (Billups-Rothenberg Inc., San Diego, USA), 
which was flushed with a gas mixture of 0.2% O2, 5% CO2 and 94.8% N2. An electronic oxygen analyser (Teledyne Analytical Instruments, 
California, USA) was used to confirm the O2 concentration (0.2%) before the chamber was sealed.  The cells were incubated at 37 C for 2 h 
followed by reoxygenation for 6 h in a humidified incubator (95% air, 5% CO2 at 37 C). Both hypoxic and reoxygenation conditions were carried 
out in serum- and glucose-free media. 
2.3 Cell viability – MTT assay 
Cellular toxicity arising from HR-induced oxidative stress and the effects of flavonoids or their metabolites were analysed in HTR-8/SVneo cells 
using the methyl thiazolyl tetrazolium bromide method (Sigma-Aldrich, Poole, UK). Briefly, cells were cultured in a 24-well flat-bottomed tissue 
culture plate at density of 5 × 104 cells per well and cultured for 24 h in supplemented RPMI-1640. Subsequently, these cells were incubated for 1 
h in 0.5mg/ml MTT before the medium was discarded and the formazan crystals produced dissolved in 200µl of DMSO. Cell viability was 
determined by measuring absorbance of the solubilized formazan product at 570 nm. 
2.4 CellTox™ Green Cytotoxicity Assay 
Changes in membrane integrity, which occurred as a result of cell death, in HTR-8/SVneo cells treated with flavonoids or their metabolites were 
analysed using CellTox™ green cytotoxicity assay (Promega, Southampton, UK) following the manufacturer’s instructions (technical bulletin 
number TM375). HTR-8/SVneo cells were cultured in a 96-well black with clear bottom tissue culture plate (Falcon®, Fisher Scientific, 
Loughborough, UK) at a density of 2 × 104 cells per well and incubated for overnight to allow the cells to adhere to the surface before treating 
with flavonoids or their metabolites for 24 h. CellTox™ green reagent (2X) was prepared according to the manufacturer’s instructions (1:1 with 
treatment medium) and added to all experimental wells. The plate was mixed briefly using an orbital shaker (500-700 rpm) and kept at room 
temperature for 15 min. Fluorescence was measured at 485 nm (excitation) and 520 nm (emission) using a FLUOstar Omega plate reader (BMG 
LABTECH, Aylesbury, UK).  
2.5 CellTiter-Glo® Luminescent Cell Viability Assay 
Cell proliferation, based on quantitation ATP, was measured in HTR-8/SVneo cells treated with flavonoids or their metabolites for 24 h prior to 
HR-induced oxidative stress using CellTiter-Glo® Luminescent Cell Viability Assay (Promega, Southmpton, UK) following the manufacturer’s 
instructions (technical bulletin number TB288). Briefly, cells were cultured in a 96-well black with clear bottom tissue culture plate (Falcon®) and 
adjusted to a concentration of 5 × 104 cells per well. Cells were incubated overnight before being treating with flavonoids or their metabolites prior 
to HR exposure. The CellTiter-Glo® substrate was prepared according to the manufacturer’s instructions before being added 1:1 to the appropriate 
(all experimental) wells.  Plates were mixed briefly using an orbital shaker (2 min) to induce cell lysis and kept at room temperature for 30 min. 
Luminescence was recorded using a FLUOstar Omega plate reader (BMG LABTECH, Aylesbury, UK).  
2.6 NADP/NADPH levels 
Detection of total oxidized and reduced nicotinamide adenine dinucleotide phosphates (NADP+ and NADPH) was determined using the 
NADP/NADPH-Glo™ Assay (Promega, Southampton, UK) following the manufacturer’s instructions (technical bulletin number TM400). Cells 
were cultured, at a concentration of 2 × 104 cells/well, in a 96-well black with clear bottom tissue culture plate (Falcon®) and incubated overnight 
before treating with flavonoids or their metabolites for a further 24 h. NADP/NADPH-Glo™ detection reagent was prepared according to the 
manufacturer’s guidelines. NADP/NADPH™. Detection reagent was added to samples (1:1), mixed and kept at room temperature for 60 min. 
Luminescence was recorded using a FLUOstar Omega plate reader (BMG LABTECH, Aylesbury, UK).  
2.7 ROS-Glo™ H2O2 Assay 
Production of hydrogen peroxide (H2O2) was measured using ROS-Glo
™ assay (Promega, Southampton, UKk). Cells were cultured (2 × 104 
cells/well) in a 96-well black with clear bottom tissue culture plate (Falcon®) as previously described. ROS-Glo™ H2O2 detection solution was 
prepared according to the manufacturer’s guidelines (technical bulletin number TM391) and added to all experimental wells (1:1). After 20 min 
at room temperature, luminescence was measure using a FLUOstar Omega plate reader (BMG LABTECH, Aylesbury, UK). 
2.8 GSH/GSSG-Glo™ Assay 
Detecting and quantification of total glutathione (GSH + GSSG), oxidized glutathione (GSSG) and GSH/GSSG ratios was carried out using 
GSH/GSSG-Glo™ assay (Promega, Southampton, UK). Cells were cultured and treated as described previously. After hypoxia/reoxygenation 
insult, the media were discarded and replaced with either total glutathione lysis reagent or oxidized glutathione lysis reagent and the cells were 
agitated for 5 min. Both plates were kept at room temperature for 30 min before luciferin generation reagent was added. The plates were briefly 
agitated in an orbital shaker and allowed to equilibrate at room temperature for 15 min. Luminescence was measured using a FLUOstar Omega 
plate reader (BMG LABTECH, Aylesbury, UK) and the GSH/GSSG ratio was calculated according to the manufacturer’s guidelines. 
2.9 Caspase-Glo® 3/7 Assay 
Caspase-Glo® 3/7 assay (Promega, Southampton, UK) measures caspase-3 and -7 activities in cultured cells. HTR-8/SVneo cells were cultured 
and treated as described previously. Caspase-Glo® 3/7 reagent was added to each well before mixing gently on a plate shaker for 30 sec. The plate 
was kept at room temperature for 45 min before luminescence was recorded using a FLUOstar Omega plate reader (BMG LABTECH, Aylesbury, 
UK).  
Statistical analysis 
All experiments were performed at least three times. Data are presented as mean + SEM (standard error of mean) calculated using GraphPad® 
Prism-7 Software. Statistical analyses were performed using one-way ANOVA followed by Dunnett’s multiple comparisons test to determine any 
differences between the means. A probability value of P <0.05 was considered to be statistically significant   
3.0 Results and Discussion 
The aim of this investigation was to establish whether flavonoids or their metabolites, which typically occur in food derived from edible plant are 
associated with reduced HR-induced oxidative stress in early human first trimester extra villous trophoblasts. The role of oxidative stress in the 
pathophysiology of numerous diseases has been well documented and HR insult leads to reduced trophoblast invasion, resulting in preeclampsia 
(Feng et al., 2017; Gathiram & Moodley, 2016; Hung & Burton, 2006; Sagrillo-Fagundes, Laurent, Bienvenue-Pariseault, & Vaillancourt, 2018). 
In this study, we investigated the cytoprotection associated with dietary flavonoids or their metabolites alone or in combination, during HR-induced 
oxidative stress, examining cell viability, proliferation, apoptosis, ROS modulation and oxidized glutathione prior to HR-induced oxidative stress. 
3.1 Optimization of non-toxic flavonoid concentrations 
To our knowledge, there are no previous studies using the transformed human first trimester early trophoblast cell line (HTR-8/SVneo) in which 
the impact of non-toxic concentrations of flavonoids and their metabolites on HR-induced oxidative stress is examined. We selected a range of 
concentrations (1-40 µM), based on previous studies carried out on non-trophoblast cell lines (Daubney et al., 2015; PeiMing, HoHsing, ChihWen, 
WenShu, & ShuJun, 2012; Yamamoto et al., 2013). MTT and CellTox™ green cytotoxicity assays were used to determine the non-toxic working 
concentrations of flavonoids (quercetin, hesperidin) and their metabolites (Q3G, hesperetin). As shown in Figure 1 (A-D), which are based on 
results for the MTT assay, flavonoid concentrations above 10 µM were toxic to the cell line HTR-8/SVneo. These results were also validated using 
the CellTox™ green cytotoxicity assay (Figure 1, E-H), which monitors cell membrane integrity, and confirmed that concentrations of above 10 
µM triggered cell death. It should be noted that previous studies used concentrations of flavonoids above typical plasma concentrations, which 
could not be achieved through daily dietary intake of fruits/fruit products. The concentrations of flavonoids used within this study could be achieved 
from daily intake of fruits and vegetables (Zhang et al., 2015). However, it is difficult to determine amounts that reach the placenta (Feghali, 
Venkataramanan, & Caritis, 2015), mainly due ethical constraints around foetal safety. Our results showed that concentrations of flavonoids 
(quercetin/hesperidin) and their metabolites (Q3G/hesperetin) above 10 µM displayed marked toxicity to human trophoblast cell line (HTR-
8/SVneo). 
Since the concentrations of 3 µM for flavonoids and 1 µM for their metabolites were non-toxic, their combined effects were studied to mimic the 
situation in vivo, where both flavonoids and their metabolites would occur in tissues. Referencing a previous study by Manach, Morand, Gil-
Izquierdo, Bouteloup-Demange, & Rémésy (2003), flavonoids are hydrolysed in the liver after a few hours of ingestion. Further studies have 
revealed that metabolites, as well as the parent flavonoids, are found in both plasma and urine of human subjects (Erlund, Meririnne, Alfthan, & 
Aro, 2001; Procházková et al., 2011). Other studies showed that oral administration of quercetin or hesperidin mainly increased plasma 
concentrations of their metabolites (e.g. Q3G and hesperetin) (Chan et al., 2014; Ting, Yeh, & Lien, 2011; Yamamoto et al., 2013). In addition, 
studies have also found that the amounts of metabolites recovered were significantly less than the amounts of flavonoid ingested (Erlund et al., 
2001; Procházková et al., 2011). It is thus important to study the combined effects of individual flavonoids and their metabolites. Combinations of 
flavonoids at 3 µM or their respective metabolites at 1 µM (quercetin + Q3G and hesperidin + hesperetin) showed no toxicity. Therefore, these 
non-toxic concentrations were selected for subsequent experiments.  
3.2 Oxidative stress model 
An oxidative stress model was achieved by exposing the HTR-8/SVneo cells to either 2 h hypoxia (0.2% O2) or 2 h hypoxia followed by 6 h of 
re-oxygenation in a humidified incubator (95% air/5% CO2 at 37 ⁰C) in serum- and glucose-free media. Exposure of HTR-8/SVneo cells to hypoxia 
alone increased cell viability (MTT assay). Similarly, the CellTox™ green cytotoxicity assay revealed no significant difference in cell death between 
control and hypoxia treated cells. In contrast, upon re-oxygenation (HR), there was a statistically significant reduction in cell viability (MTT assay) 
and increased cell death (CellTox™ green cytotoxicity assay). There is a considerable body of evidence indicating that trophoblast cells are 
accustomed to hypoxia (either 0.2 or 2% O2). Our data were in agreement with these studies, suggesting that in HTR-8/SVneo cells, hypoxia alone 
triggers an increase in cell viability (MTT assay) and reduced cell death (CellTox™ green cytotoxicity assay). Oxidative stress was established 
through re-oxygenation, using a protocol modified from previous studies (Armant et al., 2006; Leach, Kilburn, Petkova, Romero, & Armant, 
2008). Hypoxia (2 h) followed by reoxygenation (6 h) triggered a robust MTT reduction (MTT assay) and decreased membrane integrity in HTR-
8/SVneo cells, indicating these conditions provided a suitable cell-based model for HR-induced oxidative stress to study the impact of flavonoid 
supplementation. Therefore, an oxidative stress model was established with re-oxygenation (HR), as hypoxia alone was not sufficient to induce 
cell death. 
3.3 Effects of flavonoids and metabolites on hypoxia/reoxygenation 
We sought to determine the effects of flavonoids or their metabolites on HR-induced cell death, intracellular ROS levels, and oxidized glutathione. 
To this end, HTR-8/SVneo cells were treated with flavonoids or their metabolites, alone or in combination, for 24 h prior to HR. The flavonoids 
quercetin (3 µM) and hesperidin (3 µM) were associated with significant protection against MTT reduction (Figure 2A and 3A). Similarly, their 
respective metabolites, Q3G (1 µM) and hesperetin (1 µM), were also associated with significant protection against HR-induced MTT reduction 
(Figure 2B and 3B). Comparable results were also obtained by monitoring cell proliferation, using the CellTiter-Glo® viability assay, which 
determines intracellular ATP levels (Figure 2D-E and 3D-E). In addition, combinations of flavonoids, with their respective metabolite (quercetin 
+ Q3G and hesperidin + hesperetin), were also associated with statistically significant protection against HR-induced MTT reduction (Figure 2C 
and 3C) and intracellular ATP levels (Figure 2F and 3F). This data is in agreement with other studies conducted in non-trophoblast cells. Previous 
studies showed that the presence of quercetin and Q3G was associated with cardioprotection in mitotic and differentiated H9c2 cardiomyocytes 
(Daubney et al., 2015). Other studies by Ho & Chang (2004) and Shokoohinia, Hosseinzadeh, Moieni-Arya, Mostafaie, & Mohammadi-Motlagh 
(2014) showed that neuronal cells (PC12) pre-incubated with quercetin and Q3G were also protected against H2O2-induced oxidative stress. 
Hesperidin (at 20-80µM) was found to be protective in human hepatic (L02) cells, following tert-butyl hydroperoxide-induced oxidative stress 
(Chen et al., 2010; Choi & Ahn, 2008). These authors also reported that hesperidin (at 20-80µM) activated antioxidant defence systems in mice 
subjected to oxidative stress. Indeed, studies have reported that either flavonoids or their metabolites, alone or in combination, could induce 
antioxidant defence systems (Chen et al., 2010; Shokoohinia et al., 2014). Most importantly, the concentrations used herein fall within a 
physiologically achievable range. We also investigated the effects of combinations of flavonoid metabolites (quercetin + Q3G and hesperidin + 
hesperetin). Our findings showed this combination was protective against HR-induced oxidative stress. To our knowledge, this is the first report 
of flavonoid/metabolite combinations being used to protect these cells. Although comparable data from previous studies using trophoblast cells 
are not available, studies using a pancreatic ductal ademonocarcinoma cell line (BxPc-3) and primary cells showed that combination of flavonoids 
provide? more protection than single flavonoid treatment during oxidative stress (Appari, Babu, Kaczorowski, Gross, & Herr, 2014). 
3.4 Effects of flavonoids, metabolites and combinations on ROS  
We examined the effects of flavonoids or their metabolites, alone or in combination, on ROS in HTR8/SVneo cells. As shown in Figures 4 and 5, 
pre-treatment (24 h) of cells with quercetin and hesperidin prior to HR was associated with a reduction in superoxide (NADP/NADPH; Figure 4A-
C and 5A-C), hydrogen peroxide (H2O2; Figure 4D-F and 5D-F) and oxidized glutathione (GSSG; Figure 4G-I and 5G-1) compared with control 
cells. Similar results were also obtained for their respective metabolites, Q3G and hesperetin, as well as combinations of flavonoids with their 
metabolites. Our findings are in agreement with previous studies on non-trophoblast tissues/ cells (Hwang & Yen, 2011; Jiang, Guo, & Dusting, 
2008; Shaban, Ahmed, El‑rashidy, & Kodous, 2017). For example, in vascular smooth muscle cells, quercetin and its metabolite Q3G inhibited 
NADPH oxidase and decreased H2O2 generation (Jiang et al., 2008; Jimenez et al., 2015). The antioxidant properties of flavonoids have been 
attributed to their ability to scavenge O2
- free radical. Indeed, quercetin is a potent scavenger of O2
-  (Jiang et al., 2008). Another study showed 
that hesperidin exhibited protection against gamma irradiation in rat testis (Shaban et al., 2017). Furthermore, hesperetin has been found to be 
neuroprotective against the effects of H2O2 in PC12 cells (Hwang & Yen, 2011). Other studies have shown that flavonoids inhibit enzymes 
responsible for superoxide production (Procházková et al., 2011). Flavonoids have also been shown to activate antioxidants, by inducing phase II 
detoxifying enzymes of the free radical scavenging system (Heim et al., 2002; Procházková et al., 2011). Quercetin and other flavonoids might 
also protect cells from oxidative stress through metal chelation (Procházková & Wilhelmová, 2011). 
To summarise, our findings showed that HR-induced oxidative stress significantly increased concentrations of GSSG, which is an important bio-
indicator. These data are similar to another study conducted by Shaban et al. (2017), which showed that gamma radiation-induced oxidative stress 
increased GSSG concentrations, which decreased following hesperetin treatment. Also,  Molina, Sanchez-Reus, Iglesias, & Benedi (2003) found 
that, in mouse liver, oxidative stress (triggered by chronic ethanol treatment) induced increased GSSG, which was inhibited by pre-treatment with 
quercetin and is in agreement with our findings. 
3.5 Effects of flavonoids, metabolites alone or in combinations on caspase 3/7 
We also investigated the effects of flavonoids or their metabolites on apoptosis by assessing caspase 3/7 activities. Both quercetin and hesperidin 
were associated with a significant reduction in HR-induced caspase 3/7 activation (Figure 6A and 7D). Similarly, Q3G and hesperetin were 
associated with attenuation of HR-induced caspase 3/7 activation (Figure 6B and 6E). Finally, comparable results were also obtained for flavonoid 
metabolite combinations (quercetin + Q3G, hesperidin + hesperetin), as shown in Figure 6C and 6F. These data suggest flavonoids or their 
metabolites on apoptosis are protective against HR-induced apoptosis in HTR-8/SVneo cells.  Shaban et al. (2017) also found that hesperetin had 
a protective role against apoptosis induced by gamma radiation in rat testes. Likewise, hesperidin and its metabolite decreased apoptosis (caspase 
3) in neuronal PC12 cells after oxidative stress (Bournival, Quessy, & Martinoli, 2009). These results were also confirmed by studies in vivo in 
rats (Ahmad et al., 2012; Shaban et al., 2017; Shagirtha, Bashir, & Miltonprabu, 2017).  
4.0 Conclusions  
This study has shown for the first time that 24 h treatment with flavonoids or their metabolites, alone or in combination, is associated with 
cytoprotective effects against HR-induced oxidative stress in a trophoblast cell line (HTR-8/SVneo). Also, the formation of ROS was reduced 
significantly by flavonoids or their metabolites in the same trophoblast cell line. The protective effects might be brought about via a reduction in 
caspase 3/7 activation. Regardless, these findings suggest that increasing intake of fruits and vegetables, rich in flavonoids, might protect against 
oxidative stress during pregnancy. Further studies are required to explore the complex interplay between the numerous signalling pathways that 
are modulated by flavonoids and metabolites or their combinations in protecting against oxidative stress in trophoblasts. 
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Figure Captions 
Figure 1: Optimization of non-toxic concentrations of flavonoids and their metabolites 
HTR-8/SVneo cells were exposed to the indicated concentrations of flavonoids (quercetin and hesperidin) or metabolites (Q3G and hesperetin) 
for 24 h. Following flavonoid/metabolite exposure, cell viability was assessed by measuring (A-D) metabolic reduction of MTT by mitochondrial 
dehydrogenases and (E-H) membrane integrity via the CellTox™ green cytotoxicity assay. For the MTT reduction assays the data are expressed as 
the percentage of control cells (=100%) and for CellTox™ green cytotoxicity assays data are expressed as relative florescence unit. Data represent 
the mean  SEM of ≥ 7, each performed in quadruplicate. *P0.05 versus control response. 
 
Figure 2: Cytoprotective effects of quercetin, Q3G or in combination 
HTR-8/SVneo cells were treated with quercetin (3 µM) or Q3G (1 µM)  or in combination for 24 h prior to exposure to HR. Cell viability was 
assessed by measuring (A-C) metabolic reduction of MTT by mitochondrial dehydrogenases and (D-F) intracellular ATP levels using the Celltiter-
Glo® viability assay. Data are presented as the percentage of control (MTT assay) or relative luminescence units (Celltiter-Glo® viability assay) 
and represent the mean + SEM of ≥ 5, each performed in quadruplicate. *p<0.05 versus control HR. 
 
Figure 3: Cytoprotective effects of hesperidin, hesperetin or in combination. 
HTR-8/SVneo cells were treated with hesperidin (3 µM) or hesperetin (1 µM)  or in combination for 24 h prior for 24 h prior to exposure to HR. 
Cell viability was assessed by measuring (A-C) metabolic reduction of MTT by mitochondrial dehydrogenases and (D-F) intracellular ATP levels 
using the Celltiter-Glo® viability assay. Data are expressed as the percentage of control (MTT assay) or relative luminescence units (Celltiter-Glo® 
viability assay) and represent the mean + SEM of ≥ 5 (MTT) or ≥ 4 (CellTiter-Glo®) independent experiments each performed in quadruplicate. 
*p<0.05 versus HR untreated cells. 
 
Figure 4: Scavenging of ROS by quercetin, Q3G or in combination.  
HTR-8/SVneo cells were treated with the indicated concentrations of flavonoids/metabolites or combinations for 24 h before exposure to HR. 
ROS production was assessed by (A-C) superoxide generation by measuring NADP/NADPH ratios, (D-F) H2O2 generation and (G-I) oxidized 
glutathione (GSSG) generation. Data are presented as relative luminescence units and represent the mean + SEM of ≥ 5 each performed in 
quadruplicate. *p<0.05 versus HR untreated cells 
 
Figure 5: Scavenging of ROS by hesperidin, hesperetin or in combination. 
HTR-8/SVneo cells were treated with the indicated combinations of flavonoids (3 µM) and metabolites (1 µM)  or in combination for 24 h prior 
to exposure to HR. ROS production was assessed by (A-C) superoxide generation by measuring NADP/NADPH ratios, (D-F) H2O2 generation 
and (G-I) oxidized glutathione (GSSG) generation. Data are expressed as relative luminescence units and represent the mean + SEM of ≥ 4 each 
performed in quadruplicate. *p<0.05 versus HR untreated cells. 
 
Figure 6: The effects of flavonoids, their metabolites alone or in combination on caspase activity 
HTR-8/SVneo cells were treated with flavonoids (3 µM) and metabolites (1 µM) or in combination for 24 h prior to HR exposure. Following HR, 
caspase activity was assessed using the Caspase-Glo® 3/7 assay. Data are presented as relative luminescence units and represent the mean + SEM 
of ≥ 5 each performed in quadruplicate. *p<0.05 versus HR untreated cells. 
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